ELYSIUM THERAPEUTICS, INC.
Creating safer, more effective solutions for pain management and the opioid crisis
Akron, United States · Founded 2015
- Headquarters
- Akron, Ohio
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- elysiumrx.com
- Last Round
- SeedJan 2026
- Rounds
- 2
About
Elysium Therapeutics is a pharmaceutical company developing abuse-deterrent and diversion-resistant opioid formulations using their proprietary molecular deactivation (XpiRx) technology. Their SMART product solutions, including O2P (Oral Overdose Protected hydrocodone) and SOOPR (a rescue agent for synthetic opioid overdose), have demonstrated human proof-of-concept. The company has received approximately $16M in NIH SBIR and non-dilutive grant funding.
Summary
ELYSIUM THERAPEUTICS, INC. is a Biotech company based in Akron, United States, founded in 2015. Its most recent funding was a Seed round in Jan 2026. Investors include Mesa Verde Venture Partners and New York Angels.
Funding History
Jan 2026
Sign up to see all 2 rounds
Seed through SAFE — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elysium-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/elysium-therapeutics-inc" alt="ELYSIUM THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>